Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Barlas

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|April 20, 2013
Hospitals prepare for medicare cuts: the need to reduce the federal deficit puts seniors and providers on noticeStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 4, 2013
DHHS Pushes to Expand E-Prescribing: Accessing Formularies in Health Plans Is a Major ProblemStephen Barlas
Biotechnology Healthcare|February 21, 2013
Opening the door to follow-on proteins?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|December 18, 2014
Generic prices take flight: the FDA is struggling to ground themStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 25, 2016
340B Guidance Riles Hospitals, Drug Makers: They Push in Opposite Ways on Eligibility, Discounts, and MoreStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 8, 2017
FDA Guidance on Biosimilar Interchangeability Elicits Diverse Views: Current and Potential Marketers Complain About Too-High HurdlesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|December 14, 2017
"Right to Try" Legislation Moving Through Congress: But Drug Companies and Some Patient Groups Want ChangesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 16, 2019
Biosimilar Roadblock Removals Seem Tailor-Made for Trump/Democrats Agreement: Development of New Biosimilar Drugs and Marketing of Few Approved Drugs StymiedStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 2, 2019
Trump Administration Announces Long-Awaited Rebate Changes: One Safe Harbor Eliminated, Two Others CreatedStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 2, 2019
Democratic Takeover of House Sparks Drug-Price Legislation Talks: But Strong Legislation Unlikely Given Patient and Industry OppositionStephen Barlas
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
P & T : a Peer-Reviewed Journal for Formulary Management|April 20, 2013
Hospitals prepare for medicare cuts: the need to reduce the federal deficit puts seniors and providers on noticeStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 4, 2013
DHHS Pushes to Expand E-Prescribing: Accessing Formularies in Health Plans Is a Major ProblemStephen Barlas
Biotechnology Healthcare|February 21, 2013
Opening the door to follow-on proteins?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|December 18, 2014
Generic prices take flight: the FDA is struggling to ground themStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 25, 2016
340B Guidance Riles Hospitals, Drug Makers: They Push in Opposite Ways on Eligibility, Discounts, and MoreStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 8, 2017
FDA Guidance on Biosimilar Interchangeability Elicits Diverse Views: Current and Potential Marketers Complain About Too-High HurdlesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|December 14, 2017
"Right to Try" Legislation Moving Through Congress: But Drug Companies and Some Patient Groups Want ChangesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 16, 2019
Biosimilar Roadblock Removals Seem Tailor-Made for Trump/Democrats Agreement: Development of New Biosimilar Drugs and Marketing of Few Approved Drugs StymiedStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 2, 2019
Trump Administration Announces Long-Awaited Rebate Changes: One Safe Harbor Eliminated, Two Others CreatedStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 2, 2019
Democratic Takeover of House Sparks Drug-Price Legislation Talks: But Strong Legislation Unlikely Given Patient and Industry OppositionStephen Barlas
Pageof 15